cas 2052969-21-6|| where to buy 3-Chloro-4-methyl-5-[(phenoxycarbonyl)amino]benzenesulfonic acid

Produktname:3-Chloro-4-methyl-5-[(phenoxycarbonyl)amino]benzenesulfonic acid

IUPAC Name:3-chloro-4-methyl-5-[(phenoxycarbonyl)amino]benzene-1-sulfonic acid

: CAS：2052969-21-6; Molekulare Formel：C14H12ClNO5S; Reinheit：95%

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2052969-21-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:2052969-21-6; Molekulare Formel:C14H12ClNO5S; Schmelzpunkt:-; SMILES-Code:O=C(OC=1C=CC=CC1)NC2=CC(=CC(Cl)=C2C)S(=O)(=O)O; Dichte:

: Katalognummer:CM1078469; Molekulargewicht:341.76; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Upacicalcet; Pathalys pharma secures $105 million series B financing. Oversubscribed financing paves path to NDA submission and pre-commercialization efforts for upacicalcet.
Upacicalcet is a novel calcimimetic that can be delivered intravenously at the end of the hemodialysis session via pre-filled syringe and has been demonstrated to effectively reduce levels of parathyroid hormone(PTH) and may have a better tolerability profile for patients. Upacicalcet can be used in secondary hyperparathyroidism (SHPT) to address an unmet need in the management of advanced chronic kidney disease (CKD).